TolerRx, Inc. Company Profile
We are a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with immunological diseases. TolerRx has a development pipeline which includes two humanized antibodies that are in clinical trials for new-onset type 1 diabetes, psoriasis, and cutaneous lupus erythematosus. We also have ongoing research and development programs focused on generating new monoclonal antibody and small molecule products for the treatment of immunological diseases.
Location
300 Technology Square3rd Floor
Cambridge
Massachusetts
02139
United States of America
Contact
Phone: 617-354-8100
Fax: 617-354-8300
Email: info@TolerRx.com
News Articles
None
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
TolerRx, Inc. is an emerging biopharmaceutical enterprise specializing in the discovery, development, and commercial launch of a novel class of therapies that induce and/or maintain immunological tole...
TolerRx, Inc. is an emerging biopharmaceutical enterprise specializing in the discovery, development, and commercial launch of a novel class of therapies that induce and/or maintain immunological tole...
We are a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with immunological diseases. TolerRx has a development pipeline whi...
More Information about "TolerRx, Inc." on BioPortfolio
We have published hundreds of TolerRx, Inc. news stories on BioPortfolio along with dozens of TolerRx, Inc. Clinical Trials and PubMed Articles about TolerRx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TolerRx, Inc. Companies in our database. You can also find out about relevant TolerRx, Inc. Drugs and Medications on this site too.
